Clinical Features and Short-Term Growth Hormone Outcomes in Maternal Uniparental Disomy of Chromosome 20: Five Chinese Patients and a Literature Review
Hormone Research in Paediatrics · 05.10.2026 · 1-1
DOI: 10.1159/hrp/adaag033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 05.10.2026. Verfasst von Hui Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism, and Genetic Disease, Children's Hospital of Soochow University, Suzhou, China. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Introduction
Maternally derived uniparental disomy of chromosome 20 (UPD(20)mat), also known as Mulchandani-Bhoj-Conlin syndrome, is a rare imprinting disorder with fewer than 30 patients documented to date. It is characterized by prenatal and postnatal growth failure and feeding difficulties. Herein, we aimed to summarize the clinical and growth characteristics of UPD(20)mat and describe short-term growth outcomes during recombinant human growth hormone (rhGH) exposure in affected individuals.
Methods
We retrospectively analyzed 5 Chinese children with UPD(20)mat genetically evaluated by whole-exome sequencing, methylation-specific multiplex ligation-dependent probe amplification, or short tandem repeat analysis. Clinical manifestations and growth data were collected. Four patients received rhGH therapy and were evaluated for changes in height standard deviation scores (Ht-SDS). In addition, we conducted a structured narrative review of 23 previously published patients identified in PubMed, China National Knowledge Infrastructure, and WanFang through July 19, 2026.
Results
The cohort included three female and two male children, with a median age at diagnosis of 3.4 years. Predominant features included advanced maternal age, postnatal feeding difficulties with low body mass index, and low absolute serum insulin-like growth factor-1 concentrations in the available records. Facial dysmorphism was mild and predominantly characterized by a prominent forehead and relative macrocephaly. Neurodevelopmental delay was noted in 4/5 patients. After rhGH treatment (duration: 10–15 months), the four treated patients showed substantial short-term catch-up growth, achieving a mean annualized height velocity of 10.7 cm/year and a mean increase in Ht-SDS of +1.18 (range: +0.7 to +2.0). The narrative review identified postnatal growth failure (93%) and feeding difficulties (100%) as cardinal features.
Conclusion
To our knowledge, this study reports the largest case series of Chinese patients with UPD(20)mat to date, highlighting that neurodevelopmental delay and hypotonia are frequent features of this condition. Recombinant human growth hormone exposure was associated with short-term increases in linear growth, but the findings are exploratory and do not establish efficacy. Compared with Silver-Russell syndrome, facial dysmorphism was mild and nonspecific, underscoring the importance of early genetic testing in children with unexplained early-onset growth failure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Metabolism, and Genetic Disease, Children's Hospital of Soochow University, Suzhou, China.
- Department of Pediatrics, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Pediatrics, Yichang Central People's Hospital, Yichang, China.
- Department of Endocrinology, Genetics and Metabolism, Children's Hospital affiliated to Zhengzhou University, Zhengzhou, China.
- Department of Endocrinology, Genetics and Metabolism, Children's Hospital affiliated to Zhengzhou University, Zhengzhou, China, haiyanwei2009@163.com.
- Department of Endocrinology, Metabolism, and Genetic Disease, Children's Hospital of Soochow University, Suzhou, China, hainewhy@126.com.
Zitieren
APA
Sun, H., Chen, X., Chen, M., Cai, Z., Li, Y., Wang, F., Xie, R., Chen, T., Chen, L., Wang, X., Yang, B., Wei, H., & Wu, H. (2026). Clinical Features and Short-Term Growth Hormone Outcomes in Maternal Uniparental Disomy of Chromosome 20: Five Chinese Patients and a Literature Review. Hormone Research in Paediatrics, 1-1. https://doi.org/10.1159/hrp/adaag033
Vancouver
Sun H, Chen X, Chen M, Cai Z, Li Y, Wang F, et al. Clinical Features and Short-Term Growth Hormone Outcomes in Maternal Uniparental Disomy of Chromosome 20: Five Chinese Patients and a Literature Review. Hormone Research in Paediatrics. 2026:1-1. doi:10.1159/hrp/adaag033
BibTeX
@article{Sun2026,
author = {Sun, Hui and Chen, Xiuli and Chen, Min and Cai, Zhengwei and Li, Yuan and Wang, Fengyun and Xie, Rongrong and Chen, Ting and Chen, Linqi and Wang, Xiaoyan and Yang, Bingyu and Wei, Haiyan and Wu, Haiying},
title = {Clinical Features and Short-Term Growth Hormone Outcomes in Maternal Uniparental Disomy of Chromosome 20: Five Chinese Patients and a Literature Review},
journal = {Hormone Research in Paediatrics},
year = {2026},
pages = {1--1},
doi = {10.1159/hrp/adaag033}
}
EUVIMED